RENAL ANGIOMYOLIPOMA
Clinical trials for RENAL ANGIOMYOLIPOMA explained in plain language.
Never miss a new study
Get alerted when new RENAL ANGIOMYOLIPOMA trials appear
Sign up with your email to follow new studies for RENAL ANGIOMYOLIPOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests drug to shrink kidney tumors in rare genetic disorder
Disease control OngoingThis study looks at the safety and effectiveness of the drug everolimus in Taiwanese adults with tuberous sclerosis complex who have kidney tumors called angiomyolipomas. Four participants will take the medication to see if it reduces tumor size and to monitor any side effects. T…
Matched conditions: RENAL ANGIOMYOLIPOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New device aims to starve tumors by cutting their blood supply
Disease control OngoingThis study tests a new device called GPX® Embolic Device for blocking blood flow to tumors and other areas in the body. About 114 adults who need this procedure will take part. The goal is to see if the device is safe and works well at reaching and blocking small blood vessels.
Matched conditions: RENAL ANGIOMYOLIPOMA
Phase: NA • Sponsor: Fluidx Medical Technology, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC